Total Payments
$31,382
2023 Payments
$3,994
Companies
33
Transactions
1,727
Medicare Patients
1,049
Medicare Billing
$526,729
Payment Breakdown by Category
Food & Beverage$31,284 (99.7%)
Education$97.94 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $31,284 | 1,721 | 99.7% |
| Education | $97.94 | 6 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $5,877 | 377 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $3,344 | 148 | $0 (2023) |
| Allergan, Inc. | $3,037 | 214 | $0 (2020) |
| ITI, Inc. | $2,274 | 175 | $0 (2023) |
| AbbVie Inc. | $2,107 | 93 | $0 (2023) |
| Lundbeck LLC | $2,062 | 146 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $2,022 | 70 | $0 (2023) |
| Alkermes, Inc. | $1,921 | 63 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,654 | 55 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $1,437 | 60 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $3,994 | 181 | AbbVie Inc. ($969.07) |
| 2022 | $5,315 | 274 | Sunovion Pharmaceuticals Inc. ($1,279) |
| 2021 | $5,118 | 303 | Sunovion Pharmaceuticals Inc. ($1,021) |
| 2020 | $4,443 | 266 | Sunovion Pharmaceuticals Inc. ($992.27) |
| 2019 | $4,325 | 235 | Sunovion Pharmaceuticals Inc. ($716.74) |
| 2018 | $4,690 | 267 | Allergan Inc. ($951.26) |
| 2017 | $3,497 | 201 | Sunovion Pharmaceuticals Inc. ($1,108) |
All Payment Transactions
1,727 individual payment records from CMS Open Payments — Page 1 of 70
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: PSYCHIATRY | ||||||
| 12/20/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $1.96 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.46 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.33 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: CNS | ||||||
| 12/07/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.84 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $1.94 | General |
| Category: PSYCHIATRY | ||||||
| 11/30/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Neurology | ||||||
| 11/30/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: CNS | ||||||
| 11/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $2.04 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/10/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: CNS | ||||||
| 11/09/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: Neuropsychiatry | ||||||
| 11/07/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2023 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/31/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 213 | 954 | $183,240 | $90,136 |
| 2022 | 2 | 198 | 1,443 | $278,200 | $147,790 |
| 2021 | 3 | 358 | 1,505 | $275,740 | $132,594 |
| 2020 | 4 | 280 | 1,891 | $396,150 | $156,208 |
Total Patients
1,049
Total Services
5,793
Medicare Billing
$526,729
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 756 | $143,640 | $74,178 | 51.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 180 | $30,600 | $13,066 | 42.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 18 | 18 | $9,000 | $2,892 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 185 | 1,430 | $271,700 | $145,992 | 53.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 13 | 13 | $6,500 | $1,798 | 27.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 189 | 1,101 | $209,190 | $112,484 | 53.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 152 | 387 | $58,050 | $17,756 | 30.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 17 | 17 | $8,500 | $2,353 | 27.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 194 | 1,355 | $256,000 | $110,934 | 43.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 42 | 486 | $120,350 | $38,290 | 31.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 26 | 32 | $10,800 | $4,889 | 45.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 18 | 18 | $9,000 | $2,096 | 23.3% |
About Dr. Mandeep Behniwal, M.D
Dr. Mandeep Behniwal, M.D is a Psychiatry healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679508881.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mandeep Behniwal, M.D has received a total of $31,382 in payments from pharmaceutical and medical device companies, with $3,994 received in 2023. These payments were reported across 1,727 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($31,284).
As a Medicare-enrolled provider, Behniwal has provided services to 1,049 Medicare beneficiaries, totaling 5,793 services with total Medicare billing of $526,729. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Sacramento, CA
- Active Since 07/12/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679508881
Products in Payments
- LATUDA (Drug) $5,600
- VRAYLAR (Drug) $4,957
- REXULTI (Drug) $2,725
- CAPLYTA (Drug) $2,274
- INGREZZA (Drug) $2,022
- ABILIFY MAINTENA (Drug) $1,774
- AUSTEDO (Drug) $1,320
- TRINTELLIX (Drug) $1,270
- ARISTADA (Drug) $1,009
- INVEGA SUSTENNA (Drug) $821.57
- Aristada 441 mg (Drug) $778.93
- SPRAVATO (Drug) $763.81
- PERSERIS (Drug) $646.67
- HETLIOZ (Drug) $539.19
- Fanapt (Drug) $535.93
- APLENZIN (Drug) $411.09
- Trintellix (Drug) $386.44
- Dayvigo (Drug) $358.91
- BELSOMRA (Drug) $328.83
- NUEDEXTA (Drug) $308.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Sacramento
David Smith, M.d, M.D
Psychiatry — Payments: $596,813
Psychiatry $596,813
Jacob Adams, Md, MD
Psychiatry — Payments: $300,724
Psychiatry $300,724
Robert Mccarron, D.o, D.O
Psychiatry — Payments: $60,946
Psychiatry $60,946
Janak Mehtani, M.d, M.D
Psychiatry — Payments: $29,471
Psychiatry $29,471
Dr. Wei-Hsun Liao, M.d. Ph.d, M.D. PH.D
Psychiatry — Payments: $15,066
Psychiatry $15,066
Donald Hilty, M.d., M.b.a, M.D., M.B.A
Psychiatry — Payments: $10,209
Psychiatry $10,209